<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.49319.004</object-id><label>Table 1.</label><caption><title>Competitive binding assays in CHO cells expressing MOR, DOR or KOR receptors.</title><p>Data were reported as K<sub>i</sub> in nM from two independent experiments performed in triplicate.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th valign="top">MOR <break/>[<sup>3</sup>H]DAMGO</th><th valign="top">DOR <break/>[<sup>3</sup>H]DPDPE</th><th valign="top">KOR [<sup>3</sup>H]diprenorphine</th></tr></thead><tbody><tr><td valign="top">Naltrexamine</td><td valign="top">0.26&#160;&#177;&#160;0.02<sup>a</sup></td><td valign="top">117.06&#160;&#177;&#160;8.94<sup>a</sup></td><td valign="top">5.15&#160;&#177;&#160;0.26<sup>a</sup></td></tr><tr><td valign="top">NAI-A594</td><td valign="top">60.36, 53.03</td><td valign="top">81.03, 64.93</td><td valign="top">210.8, 208.2</td></tr><tr><td valign="top">DAMGO</td><td valign="top">0.393, 0.691</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">DPDPE</td><td valign="top"/><td valign="top">0.747, 0.685</td><td valign="top"/></tr><tr><td valign="top">DynA(1-13)NH<sub>2</sub></td><td valign="top"/><td valign="top"/><td valign="top">0.973, 0.756</td></tr></tbody></table><table-wrap-foot><fn><p>DAMGO, DPDPE and DynA(1-13)NH<sub>2</sub> were tested as positive controls under the same conditions. Each data point was done in triplicate samples. <sup>a</sup> Reference: <xref ref-type="bibr" rid="bib22">Li et al. (2009)</xref>.</p></fn></table-wrap-foot></table-wrap>